Novel and highly potent histamine H3 receptor ligands. Part 3: An alcohol function to improve the pharmacokinetic profile
Olivier Labeeuw, Nicolas Levoin, Olivia Poupardin et al. · Bioorganic & Medicinal Chemistry Letters · 2013
Cited by 10 works. doi:10.1016/j.bmcl.2013.02.118
Authors
- Olivier Labeeuw
- Nicolas Levoin
- Olivia Poupardin
- Thierry Calmels
- Xavier Ligneau
- Isabelle Berrebi‐Bertrand
- Philippe Robert
- Jeanne‐Marie Lecomte
- Jean-Charles Schwartz
- Marc Capet
References
- Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor
- Passive Permeability and P-Glycoprotein-Mediated Efflux Differentiate Central Nervous System (CNS) and Non-CNS Marketed Drugs
- High constitutive activity of native H3 receptors regulates histamine neurons in brain
- Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors
- S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist.
- Inhibition of cortical acetylcholine release and cognitive performance by histamine H 3 receptor activation in rats
- The histamine H3receptor: an attractive target for the treatment of cognitive disorders
- BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, Hydrochloride], a Nonimidazole Inverse Agonist/Antagonist at the Human Histamine H3 Receptor: Preclinical Pharmacology
- Keynote review: Histamine H3 receptor antagonists reach out for the clinic
- Distinct pharmacology of rat and human histamine H3 receptors: role of two amino acids in the third transmembrane domain